United States · FDA National Drug Code directory
Unituxin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66302-014_27169364-7492-47e7-b2f5-7dc7d20e36a7
- Product NDC
- 66302-014
- Form
- INJECTION
- Composition / generic term
- DINUTUXIMAB
- Labeler
- United Therapeutics Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20150310
- Source listing expiry
- 20271231
Source-listed ingredients
- DINUTUXIMAB — 3.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 BOX (66302-014-01) / 5 mL in 1 VIAL, SINGLE-DOSE · 66302-014-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →